【極養視界】輔酶Q10之生活大爆炸

本文由專註營養科普的微信公眾平台《極養視界》_Vision授權轉載

中國臨床營養網（lcyycc）

輔酶Q10之生活大爆炸

■■

極養視點

• 輔酶Q10是脂溶性的維生素類似物，輔助各種酶的作用；

• 輔酶Q10是細胞產生能量的關鍵物質，具有抗氧化能力；

• 有一定證據支持，輔酶Q10能夠降低體內炎症，在特定人群中能改善心血管（如心衰）的健康；

• 輔酶Q10能否有效控制三高、預防老年癡呆、治療偏頭痛或預防癌症還需要更多研究去證明；

• 老年人、慢性病患者和長期服用他汀類藥物或華法林鈉片的人需要格外關注自身輔酶Q10的水準；

• 輔酶Q10的食物來源包括沙丁魚、動物肝臟、牛肉、豬肉、雞肉、十字花科蔬菜等。

■■

參考文獻

[1] Fan L, Feng Y, Chen G, Qin L, Fu C, Chen L. Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research. 2017;119:128-136. doi:10.1016/j.phrs.2017.01.032.

[2] Zhai J, Bo Y, Lu Y, Liu C, Zhang L. Effects of Coenzyme Q10 on Markers of Inflammation: A Systematic Review and Meta-Analysis. PLOS ONE. 2017;12(1):e0170172. doi:10.1371/journal.pone.0170172.

[3] Sale ST, Parvez H, Yeltiwar RK, Vivekanandan G, Pundir AJ, Jain P. A comparative evaluation of topical and intrasulcular application of coenzyme Q10 gel in chronic periodontitis patients: A clinical study. J Indian Soc Periodontol. 2014 Jul;18(4):461-5. doi: 10.4103/0972-124X.138690.

[4] Mortensen S, Rosenfeldt F, Kumar A et al. The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure. JACC: Heart Failure. 2014;2(6):641-649. doi:10.1016/j.jchf.2014.06.008.

[5] DiNicolantonio J, Bhutani J, McCarty M, O"Keefe J. Coenzyme Q10 for the treatment of heart failure: a review of the literature. Open Heart. 2015;2(1):e000326. doi:10.1136/openhrt-2015-000326.

[6] Shao L, Ma A, Figtree G, Zhang P. Combination Therapy With Coenzyme Q10 and Trimetazidine in Patients With Acute Viral Myocarditis. Journal of Cardiovascular Pharmacology. 2016;68(2):150-154. doi:10.1097/fjc.0000000000000396.

[7] Lei L, Liu Y. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials. BMC Cardiovascular Disorders. 2017;17(1). doi:10.1186/s12872-017-0628-9.

[8] Busanello E, Marques A, Lander N et al. Pravastatin Chronic Treatment Sensitizes Hypercholesterolemic Mice Muscle to Mitochondrial Permeability Transition: Protection by Creatine or Coenzyme Q10. Frontiers in Pharmacology. 2017;8. doi:10.3389/fphar.2017.00185.

[9] Okeahialam B. Reversal of statin-induced memory dysfunction by co-enzyme Q10: a case report. Vascular Health and Risk Management. 2015:579. doi:10.2147/vhrm.s90551.

[10] Suksomboon N, Poolsup N, Juanak N. Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis. Journal of Clinical Pharmacy and Therapeutics. 2015;40(4):413-418. doi:10.1111/jcpt.12280.

[11] Henriksen JE, Andersen CB, Hother-Nielsen O, Vaag A, Mortensen SA, Beck-Nielsen H. Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with Type 1 diabetes mellitus. Diabet Med. 1999;16(4):312-318.

[12] Xu Z, Huo J, Ding X et al. Coenzyme Q10 Improves Lipid Metabolism and Ameliorates Obesity by Regulating CaMKII-Mediated PDE4 Inhibition. Scientific Reports. 2017;7(1). doi:10.1038/s41598-017-08899-7.

[13] Sikorska M, Lanthier P, Miller H et al. Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson"s disease. Neurobiology of Aging. 2014;35(10):2329-2346. doi:10.1016/j.neurobiolaging.2014.03.032.

[14] Muthukumaran K, Leahy S, Harrison K et al. Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson』s disease. BMC Neuroscience. 2014;15(1):21. doi:10.1186/1471-2202-15-21.

[15] Parkinson Study Group QE3 Investigators, Beal M, Oakes D et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 2014;71(5):543-52. doi:10.1001/jamaneurol.2014.131.

[16] Zhu Z, Sun M, Zhang W, Wang W, Jin Y, Xie C. The efficacy and safety of coenzyme Q10 in Parkinson』s disease: a meta-analysis of randomized controlled trials. Neurological Sciences. 2016;38(2):215-224. doi:10.1007/s10072-016-2757-9.

[17] Negida A, Menshawy A, El Ashal G et al. Coenzyme Q10 for Patients with Parkinson";s Disease: A Systematic Review and Meta-Analysis. CNS & Neurological Disorders - Drug Targets. 2016;15(1):45-53. doi:10.2174/1871527314666150821103306.

[18] Bj?rklund G. The Adjuvant Nutritional Intervention in Cancer (ANICA) Trial. Nutrition and Cancer. 2015;67(8):1357-1360. doi:10.1080/01635581.2015.1085582.

[19] Liu H, Cheng S, Huang Y, Huang Y, Lin P. Coenzyme Q10 and Oxidative Stress: Inflammation Status in Hepatocellular Carcinoma Patients after Surgery. Nutrients. 2017;9(1):29. doi:10.3390/nu9010029.

[20] Tafazoli A. Coenzyme Q10 in breast cancer care. Future Oncology. 2017;13(11):1035-1041. doi:10.2217/fon-2016-0547.

[21] Landbo C, Almdal TP. Interaction between warfarin and coenzyme Q10. Ugeskr Laeger. 1998 May;160(22) 3226-3227. PMID: 9621803.

[22] Tarry-Adkins JL, Fernandez-Twinn DS, Madsen R, et al. Coenzyme Q10 Prevents Insulin Signaling Dysregulation and Inflammation Prior to Development of Insulin Resistance in Male Offspring of a Rat Model of Poor Maternal Nutrition and Accelerated Postnatal Growth. Endocrinology. 2015;156(10):3528-3537. doi:10.1210/en.2015-1424.

本站動態欄：

截止到 2018 年 9 月 26 號上午 8:00 時，本平台關注人數為：179036 名 。更多資訊點擊左下角閱讀原文查看。